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Deregulation of cell survival in cystic and dysplastic renal development.
Various aberrations of cell biology have been reported in polycystic
kidney diseases and in cystic renal dysplasias. A common theme in
these disorders is failure of maturation of renal cells which superficially
resemble embryonic tissue. Apoptosis is a feature of normal murine
nephrogenesis, where it has been implicated in morphogenesis, and
fulminant apoptosis occurs in the small, cystic kidneys which develop in
mice with null mutations of bcl-2. Therefore, we examined the location
and extent of apoptosis in pre- and postnatal samples of human
polycystic and dysplastic kidney diseases using propidium iodide stain-
ing, in situ end-labeling and electron microscopy. In dysplastic kidneys
cell death was prominent in undifferentiated cells around dysplastic
tubules and was occasionally found in cystic epithelia. The incidence of
apoptosis was significantly greater than in normal controls of compa-
rable age both pre- and postnatally. In the polycystic kidneys there was
widespread apoptosis in the interstitium around undilated tubules
distant from cysts, in undilated tubules between cysts and in cystic
epithelia. The level of apoptosis compared to controls was significantly
increased postnatally. A similar increase of cell death was also noted in
the early and late stages of renal disease in the polycystic cpk/cpk
mouse model. We speculate that deregulation of cell survival in these
kidneys may reflect incomplete tissue maturation, and may contribute
to the progressive destruction of functional kidney tissue in polycystic
kidneys and the spontaneous involution reported in cystic dysplastic
kidneys.
Organogenesis involves an increase in cell numbers, cell
differentiation and morphogenesis. In normal development the
increase in cell number is determined by the balance between
proliferation and death, which in this context has been called
'programmed cell death.' This term is often used interchang-
ably with 'apoptosis,' first used by Kerr, Wyllie and Currie [1]
to describe death in a variety of normal and pathological
contexts when accompanied by nuclear condensation and frag-
mentation with cell shrinkage. These changes are striking on
electron microscopy but can also be detected by light micros-
copy as pyknotic nuclei [2]. A common biochemical correlate of
apoptosis is DNA digestion by endonucleases into nucleosome
sized fragments which can be visualized as a 'ladder' on
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electrophoresis [3] and detected in situ by end-labeling [4].
Exceptionally, some programmed cell death during develop-
ment is not accompanied by these morphological events [5] and
laddering is not always detected in cells dying by morphological
criteria of apoptosis, since the DNA is sometimes cleaved into
larger fragments (50 to 300 kbp) [6]. In the worm Caenorhab-
ditis elegans apoptosis is developmentally regulated by the
expression of specific genes, and some of their mammalian
homologues have been defined [7]. 'Growth factors' not only
control proliferation and differentiation but can also enhance
apoptosis [8] or act as survival factors [9]. In contrast to
apoptosis, cells dying by necrosis swell with destruction of
organelles and loss of integrity of cell membranes [10]. DNA
laddering does not occur in necrosis, although some models
show single-strand DNA breaks [6].
In nephrogenesis cell proliferation, differentiation and morpho-
genesis occur during the branching of the ureteric bud and in
nephron formation [11—131. Apoptosis has been demonstrated
during normal murine renal development in the nephrogenic zone
and also in the papilla; cell death can be reduced by epidermal
growth factor (EGF) [2]. Koseki, Herzlinger and Al-Awqati
showed that uninduced renal mesenchyme died by apoptosis when
isolated from the ureteric bud, and that this process was amelio-
rated by EGF [14]. Similarly, hepatocyte growth factor (HGF) has
been implicated in survival of renal mesenchymal cells in serum-
free organ culture [15].
The pathogenesis of some human kidney diseases can be
understood in the context of aberrant development. In poly-
cystic kidney diseases (PKD) there is evidence of enhanced
epithelial proliferation [16] and altered polarity [17—18], lead-
ing some authors to suggest that the epithelial cells are
"locked" in an immature, dedifferentiated state [19]. Similarly,
in dysplastic kidneys there is a failure of differentiation of renal
mesenchyme into nephrons and decreased branching of the
ureteric bud [11, 20, 21]. We therefore considered it pertinent
to examine the location and quantity of apoptosis in normal
human nephrogenesis and in kidney diseases which can be
viewed as aberrations of normal nephrogenesis. In this study we
demonstrate that the distribution and incidence of renal pro-
grammed cell death is increased in children with polycystic and
dysplastic kidneys.
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Methods
Experimental strategy
The aim of the study was to define the tissue location and
quantify the extent of apoptosis during normal kidney develop-
ment and in fetal and childhood polycystic and dysplastic kidneys.
The methodologies we used included both histological and mo-
lecular techniques together with quantitative statistical analysis.
Classification of specimens
This research was approved by the hospitals' research ethics
committees. During human development the metanephros can
first be identified in the sixth week after fertilization, and sequen-
tial layers of nephrons are formed until 36 weeks after fertilization
p11]. We therefore divided our specimens into experimental
prenatal groups before 40 weeks gestation and postnatal groups
after 40 weeks as follows:
(i) Normal prenatal kidneys (N 6).
(ii) Polycystic prenatal kidneys (N = 4).
(iii) Dysplastic prenatal kidneys (N = 6).
(iv) Normal postnatal kidneys (N = 6).
(v) Polycystic postnatal kidneys (N = 4).
(vi) Dysplastic postnatal kidneys (N = 4).
Details of these patients and specimens are listed in Tables 1
and 2, including their sex, the gestational or chronological age,
associated abnormalities in other organ systems, indications for
termination of pregnancy or for removal of a kidney, plus the side
affected by renal disease and the plasma creatinine in the child-
hood samples. There was no significant difference in age and sex
distribution within the prenatal and postnatal groups. Kidney
pathology was classified by gross morphology, routine histopathol-
ogy and, in the cases of polycystic kidneys, by liver histology and
family history. All of the polycystic kidneys were classified as
autosomal-recessive polycystic kidney disease (ARPKD) apart
from one postnatal sample, which had histology consistent with
dominant disease (ADPKD), although ultrasound scans of the
parents (aged 21 and 23) were normal. Two children with ARPKD
had elevated plasma creatinines. The dysplastic samples all had
classical histological criteria of this disorder, namely dysplastic
tubules, undifferentiated 'mesenchymal' tissue and metaplastic
cartilage.
Collection of specimens
For the normal prenatal kidney group we studied both sponta-
neous miscarriages and phenotypically normal kidneys from abor-
tions performed for severe abnormalities in other organ systems
that would have compromised the survival of the fetus or infant.
These samples were compared with the polycystic and dysplastic
kidneys which were collected under similar conditions. In these
three groups the parents were given time to mourn the loss of the
child. Then the fetus was stored at 4°C until autopsy when organs
were fixed in 10% formalin. All specimens were processed within
24 hours.
The postnatal polycystic and dysplastic samples were harvested
surgically. Therefore, as a comparable normal surgical group we
used kidney tissue adjacent to, but unaffected by, Wilms' tumors.
These kidneys were chosen to control for any potential changes in
tissue morphology which may have been induced by general
anaesthesia or surgery. Since both WT1 mutations and chemo-
therapy may cause apoptosis [6, 22], we excluded children who
Table 1. Prenatal kidneys
Gestational
age
weeks Sex
Renal and associated
pathology
Normal prenatal
kidneys
17 M Abortion for neural tube defect
19 M Spontaneous miscarriage
20 F Abortion for trisomy 21 with
atrial septal defect
20 F Spontaneous miscarriage
21 M Abortion for cephalocoele
22 F Abortion for major skeletal
malformations
Polycystic prenatal
kidneys
20 M Abortion for ARPKD
34 F Spontaneous premature labor,
ARPKD
35 F Spontaneous premature labor,
liver fibrosis, ARPKD
35 M Spontaneous premature labor,
liver fibrosis, ARPKD
Dysplastic prenatal
kidneys
17 M Abortion for multicystic dysplastic
kidney with contralateral renal
agenesis
19 F Abortion for multicystic dysplastic
kidney with contralateral renal
agenesis
20 M Abortion for bilateral renal cystic
dysplasia
22 M Abortion for bilateral renal cystic
dysplasia, bladder dilated
without anatomical urethral
obstruction, atrial septal defect
24 F Abortion for bilateral renal cystic
dysplasia
34 M Spontaneous premature labor,
kidneys dysplastic, bladder
dilated with partial urethral
obstruction
Children born at 34 to 35 weeks died within hours because of respiratory
failure due to hypoplastic lungs. Chromosomes were normal in all fetuses
assessed except for the case of trisomy 21. Parents were normal by history
in all cases.
had received chemotherapy, and none of our patients had muta-
tions in the WT1 gene (personal communication, Dr. Richard
Grundy, Dept. of Haematology and Oncology, Hospital for Sick
Children, Great Ormond Street, London, UK). Surgical speci-
mens were placed on ice, examined by a pathologist and imme-
diately fixed in 10% formalin for histology. A limited number of
dysplastic samples (N = 3) were snap frozen in liquid nitrogen for
DNA extraction and fixed in glutaraldehyde for electron micros-
copy.
Detection of apoptosis by propidium iodide staining
All chemicals were supplied by Sigma (Poole, Dorset, England,
UK) unless otherwise stated. Propidium iodide is a fluorescent
dye which intercalates with nucleic acids. Apoptotic cells can be
identified in tissue sections by their small, fragmented (pyknotic)
nuclei which stain brightly when they are visualised under fluo-
rescence miscoscopy. We used the technique of Coles, Burne and
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Plasma creatinine
Side Sex pmoll/iter Renal pathology
R F 98° Diagnostic open
surgical biopsy,
ARPKDL M 14 Diagnostic open
surgical biopsy,
histological
appearance of
ADPKDR M 322° Nephrectomy at
time of renal
transplant,
ARPKDR M 50 Surgical biopsy
because of
recurrent
infections,
ARPKD
R F 50 Cystic dysplastic
upper pole with
obstruction at
pelvi-ureteric
junctionR M 33 Non-functioning
multicystic
dysplastic kidneyR M 32 Non-functioning
multicystic
dysplastic kidneyL F 38 Uilateral duplex
ureters with non-
functioning
dysplastic upper
pole
Creatinine is the immediate preoperative level.
a Two children in the polycystic group had abnormal creatinines, but
this did not appear to correlate with the pyknotic index in these specimens
(data not shown). No kidney disease was reported in any of the parents
including the histologically defined ADPKD.
Raff [2} with minor modifications. Five micrometer paraffin
sections were dewaxed through Histo-Clear (National Diagnos-
tics, Atlanta, GA, USA) twice for 10 minutes, followed by
rehydration through 100% alcohol (Hayman Ltd., Witham, Essex,
England, UK) twice for five minutes and then stepwise through
95%, 90%, 75%, 50% and 30% alcohol for three minutes each.
After washing in phosphate buffered saline (PBS, pH 7.4) for five
minutes, they were incubated in propidium iodide (4 mg/liter)
with RNase A (100 mg/liter; Unipath, Basingstoke, Hampshire,
England, UK) in PBS at 37°C for 30 minutes. After one further
wash in PBS they were mounted in CitifluorTM (Chemical Labs,
University of Kent, Canterbury, Kent, England, UK). Specimens
were examined under fluorescence (wavelength 568 nm) on a
Zeiss Axiophot microscope (Carl Zeiss, Oberkochen, Germany)
and on a Leica confocal laser scanning microscope (CLSM
Aristoplan-Leica, Heidleberg, Germany). The precise tissue loca-
tion of apoptosis was determined in ARPKD samples by counter-
staining with FITC conjugated Tetragonolobus lotus or Arachis
hypogaea lectins. These bind to proximal tubules and distal
segments (distal tubule and collecting ducts), respectively [23, 24].
After the propidium iodide staining the lectins were applied to the
sections at 1:50 dilution in PBS at room temperature for four
hours, mounted in CitifluorTM and examined under fluorescence
(wavelength 488 nm). Apoptotic nuclei detected by the propidium
iodide method were quantified by generating a pyknotic index and
by calculating the percentage of pyknotic nuclei as described
below.
Detection of apoptosis by in situ end-labeling
During apoptosis the nuclear DNA is digested by endonucle-
ases leaving free 3' ends. These ends can be tagged using terminal
deoxytransferase to add labeled nucleotides which can be visual-
ized on a tissue section using secondary detection systems. We
modified the technique of Gavrelli, Sherman and Ben-Sassoon [4]
by using an ApoptagTM kit (Oncor, Gaithersburg, MD, USA).
Paraffin sections were dewaxed and rehydrated, treated with
proteinase K (20 mg/liter) for 15 minutes and washed in PBS.
Slides were then covered with equilibration buffer for 30 seconds,
followed by terminal deoxytransferase and digoxigenin conjugated
UTP from the ApoptagTM kit as recommended by the manufac-
turer. The reaction was terminated using the ApoptagTM stop
buffer. Labeled nuclei were detected either (i) by light microscopy
after incubation with a peroxidase conjugated anti-digoxigenin
antibody and diamino benzidine (these sections were quenched
with 3% hydrogen peroxide for 15 minites at room temperature as
an initial step) or (ii) by fluorescent microscopy (wavelength 568
nm) after applying an anti-digoxigenin antibody conjugated with
rhodamine (Boehringer Mannheim, Lewes, East Sussex, UK).
Quantitation of apoptosis in human kidneys
Preliminary experiments with both propidium iodide and in situ
end-labeled specimens showed that the number of apoptotic cells
could vary between different areas of the same section, although
there was good correlation between the two techniques. There-
fore, in order to integrate the quantity of apoptosis in each
specimen we photographed 10 random fields stained with pro-
pidium iodide from throughout each sample at 20 X magnification
on a Zeiss Axiophot microscope. The number of pyknotic nuclei
was then counted by three observers in a blinded fashion, and we
derived the Pyknotic Index for each specimen by taking the mean
number of pyknotic nuclei per 10 fields. Results from each
observer were also compared to ensure that there was no observer
bias [251. In this study we have also expressed the quantity of
apoptosis as a percentage of the total number of nuclei. Since the
pyknotic indices and the percentage of apoptotic cells in each
experimental group were not normally distributed we transformed
the data by converting to log10 values, thus allowing analysis by
Table 2. Postnatal kidneys
R F 60 Wilms' tumor before
chemotherapyR M 65 Wilms' tumor before
chemotherapyL M 35 Wilms' tumor before
chemotherapyR M 48 Wilms' tumor before
chemotherapyR M 34 Wilms' tumor before
chemotherapyL F 38 Wilms' tumor before
chemotherapy
Age
months
Normal postnatal
kidneys
5
8
28
30
38
72
Polycystic postnatal
kidneys
10
11
48
72
Dysplastic postnatal
kidneys
8
15
16
60
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Fig. 1. Location of apoptosis in propidium iodide stained sections of normal and polycystic kidneys. (A) Nephrogenic zone from normal developing kidney,
20 weeks gestation. Note apoptotic nuclei in comma shaped bodies, which are primitive nephrons. (B) Glomerulus and (C) proximal tubule from normal
postnatal kidney from patient aged 30 months. Note absence of apoptosis, although nuclei in the glomerulus appear generally brighter. A fibroblast is
seen adjacent to the tubule epithelium in (C). It has a bright elongated nucleus but should not he confused with the smaller irregular pyknotic nuclei.
(D) Undilated tubule from polycystic kidney harvested at 34 weeks of gestation surrounded by numerous apoptotic nuclei in interstitial tissue. (E) is
from a child with ARPKD and shows a group of apoptotic nuclei in the interstitium between cysts. (F) is from an infant with dominant disease showing 2
apoptotic nuclei in the epithelium of a cyst close to a multilayered region of epithelium suggestive of hyperproliferation. Key: comma shaped body (c), cyst
(cy), glomemlus (g), undifferentiated renal mesenchyme (m), tubule (t) and ureteric bud (u). Arrowheads indicate apoptotic nuclei, open arrow in (A) indicates
a mitotic figure, closed arrow in (C) indicates a fibroblast and closed arrows in (F) point to multilayered epithelium. Bar is 20 rm.
Student's t-test. A probability value of P < 0.05 was considered to then in 1% Osmium tetroxide and finally embedded in epoxy
be statistically significant. resin. Ultrathin sections contrasted with uranyl acetate and lead
citrate were examined with a Jeol 100 CX transmission electron
Detection of apoptosis by electron microscopy microscope.
Apoptotic cells have a characteristic appearance on electron
microscopy with nuclear condensation around the periphery of Detection of apoptosis by DNA electrophoresis
the nucleus, cell shrinkage and budding off of both the nuclear During apoptosis endonuclease DNA digestion produces flu-
and cell membranes. Samples of three dysplastic kidneys were cleotide fragments which are multiples of 180 to 200 bases [3]
fixed initially in 2% glutaraldehyde in 0.05 M cacodylate buffer, which can be visualized as a ladder on agarose gel electrophoresis.
Fig. 2. Location of apoptotic nuclei assessed by in situ end-labeling in normal and poly cystic kidneys. (A), (C), (E) and (G) are control sections in which
the terminal deoxytransferase enzyme was omitted. Note that labeled nuclei, which appear brown, are absent. (B), (D), (F) and (H) are adjoining
sections which have been subjected to the complete end labeling proceedure. All sections counterstained with methyl green. (A) and (B). Normal mature
kidney showing apoptotic nuclei in tubular epithelial cells. This section together with Figure 1C demonstrates the range of apoptosis in normal postnatal
kidneys. (C to F) show sections from prenatal patients with ARPKD. There is a wide distribution of apoptotic nuclei in the cyst epithelium and
interstitial cells in (D) and in the epithelial cells of relatively undilated tubules adjacent to a large cyst in (F). Note that in (F) the nuclei of the flattened
epithelial cells lining the large cyst are not apoptotic, demonstrating the specificity of the technique. (G) and (H). Glomerulus from a child with ADPKD
showing a cyst of Bowman's space with apoptotic nuclei in both the cyst wall and the glomerulus. Key: cyst (cy), glomerulus (G), and tubule (t).
Arrowheads indicate apoptotic nuclei which appear brown. Bar is 40 jzm.
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Fresh surgical specimens of three dysplastic kidneys were thawed Two micrograms of DNA were subjected to electrophoresis
to room temperature (after storage at —70°C),homogenized in a
lysis buffer (10 mrt Tris HC1 (pH 8.0), 10 mri EDTA, 0.1% SDS,
100 jg/ml proteinase K) and incubated overnight at 52°C. DNA
was then extracted using the phenol/chloroform technique [26].
Briefly, equal volumes of phenol (equilibrated pH 8.0) and
chloroform were added to the specimen, which was then centri-
fuged at 5,000 x g. The aqueous layer was separated and the
process repeated. DNA was then precipitated with an equal
volume of ice cold 100% alcohol, washed in 70% ethanol and
resuspended in TE buffer (0.1 M Tris-HCI, pH 8.0, 10 mvi EDTA).
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Fig. 3. Location of apoptotic nuclei assessed bypropidium iodide and lectin staining in polycystic kidneys. All sections stained with propidiun iodide (red)
and FITC-conjugated lectin (green) are from ARPKD. (A and B) (higher power) Area of undilated distal tubules stained with Arachis hypogaea lectin
with several adjacent pyknotic nuclei. (C and D) Tetragonolobus lotus lectin staining shows proximal tubules. (C) Undilated proximal tubule next to distal
tubule with adjacent pyknotic cells and hyperproliferative epithelium. Two apoptotic cells also seen in the lumen of the distal tubule. (D) Dilated
proximal tubule on the left and dilated distal segment on the right. Three proximal tubules between cysts. One of these (right) Contains a single apoptotic
cell within its epithelium whereas the degenerating central tubule contains many apoptotic cells. Key: distal segment (d), hyperproliferative area
and proximal tubule (p). Arrowheads indicate apoptotic nuclei. Bar is 20 j.rm.
through a 1.5% agarose gel containing ethidium bromide and
visualised under UV illumination. This extraction technique
should be specific for DNA, but any potential RNA contamina-
tion was eliminated by incubating the samples with 1 mg/liter of
RNAse A for 30 minutes before electrophoresis.
Detection of apoptosis in mice with polycystic kidneys
Human ARPKD is a relatively heterogeneous condition. There-
fore, we examined apoptosis in cpk/cpk mice which phenotypically
ressemble human ARPKD, but in which the kidney histology is
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Fig. 4. Location of apoptotic nuclei in dysplastic kidneys. (A) Low power view of dysplastic kidney from a 16 months old child counterstained with
toluidine blue to show dysplastic tubules immediately surrounded by fibromuscular collarettes and adjacent areas of undifferentiated cells of
mesenchymal appearance. (B) Propidium iodide labeling showing pyknotic nuclei in the interstitium between cysts. (C to E) are in situ end labeled
sections using an anti-digoxigenin antibody conjugated to rhodamine. (C) Large dysplastic tubule with surrounding collarette containing one apoptotic
nucleus. (D) Numerous apoptotic nuclei in area of undifferentiated cells, similar to the area in (B). (E) Small dysplastic tubule with many adjacent
apoptotic nuclei. Key: collarette (Ct), dysplastic tubule (dt) and undifferentiated mesenchyme-like cells (m). Arrowheads indicate apoptotic cells. Bar
is 40 pm in A and B and 20 jm in all other sections.
more homogeneous and the progressive course of the disease is
highly predictable [18, 27, 28]. Homozygous cpk/cpk mice (Jack-
son Laboratory, ME, USA) were sacrificed at birth when there
was mild dilatation of the proximal tubules, and at day 14 when
there were gross cystic changes in the collecting ducts. The extent
of apoptosis was compared with phenotypically normal littermates
(cpk/+ and +1+) as discussed above.
Effects of storage on apoptosis in fetal mice kidneys
To assess the possible effects of storage on the quantity of renal
apoptosis we performed the following experiment. Pregnant CDI
mice (Charles River UK Ltd, Margate, England, UK) were
sacrificed by cervical dislocation at the 16th day of gestation, a
stage when the fetal kidney contained a spectrum of nephrogen-
esis broadly equivalent to our human prenatal samples. Embryos
were killed by cervical dislocation. In one group kidneys were
immediately removed and fixed in 4% PFA, while in the other
group the whole fetus was left at 4°C for 24 hours before removing
and processing the kidneys. Subsequently, apoptosis was quanti-
tated on histological sections.
Effects of anaesthesia and renal artery clamping on apoptosis
in mice
We assessed the potential effects of anaesthesia and renal artery
clamping on apoptosis by performing these procedures on mice.
Adult CD1 mice (25 g) were anaesthatized with nitrous oxide!
halothane and underwent laparotomy. The renal vessels were
identified using a dissecting microscope and the renal arteries
were clamped for 15 minutes. Mice were then sacrificed. Control
mice underwent cervical dislocation with immediate dissection
and processing of the kidneys. Apoptosis was quantitated as
above.
Results
Location of apoptosis in normal human kidneys
In prenatal kidneys apoptosis was detected in nephron precur-
sors in the nephrogenic cortex, typically in comma shaped bodies
(Fig. 1A), and in interstitial cells in the medulla (not shown).
Apoptosis was not found in either the undifferentiated mesen-
chyme (Fig. IA) or in more mature nephrons towards the center
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Fig. 5. Electron microscopy of dysplastic kidneys.
(A) Cyst wall showing apoptotic cell with
condensed pyknotic nucleus surrounded by
normal epithelial cells. The apoptotic cell
appears to be shrinking. (B) Poorly
differentiated mesenchyme showing both
normal cells and one cell undergoing apoptosis
with nuclear condensation. Key: apoptotic cells
(A), collagen (c), cyst (cy), epithelial cells (E),
fibroblast (F). Arrows indicate the tight
junctions between epithelial cells, arrowheads
indicate pyknotic nuclei. Bar is 1 jim.
of the organ. In the postnatal samples rare apoptotic nuclei were
detected in the epithelial cells of proximal tubules (Fig. 2B), but
were never noted in glomeruli (Figs. lB and 2B), interstitial cells
(Figs. IC and 2B) or loops of Henle.
Location of apoptosis in polycystic human kidneys
The distribution of apoptosis within the kidney was similar in
both pre- and postnatal samples. In ARPKD apoptosis was
detected (i) in the interstitium around undilated proximal and
distal tubules (Figs. 1D, 3 A-C); (ii) within the epithelial lining of
cysts, often adjacent to areas of epithelial hypercellularity (Figs.
IE, iF, 2D, and 3C); (iii) and in the epithelium of undilated
proximal tubules between large cysts (Fig. 3D). In the ADPKD
sample apoptosis was additionally observed within glomeruli with
cystic dilatation of Bowmans' capsule (Fig. 2H).
Location of apoptosis in dysplastic human kidneys
A similar histological pattern of cell death was seen in prenatal
and postnatal specimens. Apoptosis was prominent in areas of
undifferentiated cells (Figs. 4B, 4D and 5B) but was also, on
occasion, observed in close proximity to dysplastic tubules (Fig. 4
C, E). in the multicystic dysplastic kidneys apoptosis was rarely
detected in cystic epithelia, and areas of cartilage did not contain
apoptotic cells (data not shown). These sites of apoptosis were
confirmed on electron microscopy; Figure 5A shows an electron
micrograph of an apoptotic cell adjacent to normal epithelial cells
in the wall of a cyst. Figure 5B shows an apoptotic cell in an
undifferentiated area which resembles uninduced mesenchyme.
We found DNA laddering in two out of the three dysplastic
samples (Fig. 6), although histology revealed apoptotic nuclei in
11*111
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A B C D E F Discussion
In the adult kidney apoptosis has been implicated in animal
models of glomerulonephritis [29J and in experimental reperfu-
sion injury [30]. The results from the current study suggest that
apoptosis also occurs in dysplastic renal malformations and
childhood polycystic kidney diseases.
Apoptosis in normal kidneys
720 bp —
540 bp —*
360 bp —*
180 bp —*
Fig. 6. DNA laddering in dysplastic kidneys. DNA was extracted from
dysplastic kidneys from infants and children, then electrophoresed
through a 1.5% agarose gel as described in the Methods. Lane A and Lane
B. Dysplastic kidney showing laddering. Lane C Dysplastic kidney with no
detectable ladder. Lanes D, E and F. Samples from the same kidney as A,
B and C treated with RNAse A rule out RNA contamination.
all samples. This might be explained by the finding that DNA is
sometimes broken down into large fragments during apoptosis,
which cannot be visualized by thc laddering technique [6].
Quantification of apoptosis in human kidneys
Apoptotic cells were rare in normal postnatal kidneys, but
significantly more death was seen in normal prenatal organs (Fig.
7; P < 0.01). This difference provided the rationale for analyzing
the quantity of apoptosis in dysplastic and polycystic patient
samples in separate prenatal and postnatal groups. Dysplastic
kidneys had more apoptosis than normal kidneys of a comparable
age (Fig. 7; prenatally P < 0.001; postnatally P < 0.002), and the
absolute levels of apoptosis fell significantly between the prenatal
and postnatal period (Fig. 7; P < 0.005). In prenatal polycystic
kidneys, apoptosis was not significantly greater than the normal
group. In the postnatal period, however, a high level of cell death
was maintained, and this value was significantly higher than
normal controls (Fig. 7; P < 0.001). All postnatal polycystic
kidneys contained high levels of apoptosis irrespective of the level
of plasma creatinine (Table 2).
Apoptosis in animal experiments
Cpklcpk mice had significantly more apoptosis than their phe-
notypically normal littermates both on the first day of life, when
there was only mild dilation of the proximal tubules (Table 3; P <
0.01), and at postnatal day 14 when the kidneys were grossly
distended by distal cysts (Table 3; P < 0.01). The location of
apoptosis was similar to that seen in the human samples (data not
shown). There was no significant difference in levels of apoptosis
between mouse fetal kidneys which were either processed imme-
diately or left in situ for 24 hours at 4°C before removal and
fixation (Table 3). Similarly, no significant difference in the
quantity of apoptosis was observed in mice kidneys which had
been subjected to anaesthesia and renal artery clamping versus
organs which were immediately removed and processed (Table 3).
In normal human fetal kidneys apoptosis was detected in the
nephrogenic cortex and the medulla. In view of the high level of
apoptosis in comma-shaped bodies (Fig. 1A) we speculate that it
may be involved in both nephron morphogenesis and controlling
the number of cells within a nephron. Apoptosis also occurs
between branches of the collecting ducts [2], an area where Potter
described regression of the first generations of nephrons [11]. It
could be argued that a delay in processing human specimens may
have altered the degree of apoptosis, but we did not find any
difference in the level of cell death in embryonic mice kidneys
after prolonged storage at 4°C (Table 3). In addition, the distri-
bution of apoptosis was similar to that described in a study in rats
where developing kidneys were perfusion fixed immediately be-
fore harvesting [2]. We found a low level of apoptosis in proximal
tubules of normal postnatal specimens (Figs. 2 and 7), but
apoptosis was never observed in glomeruli, Henle loops or
interstitial cells (Figs. 1 and 2). Conflicting studies have suggested
that hypoxia/ischemia causes apoptosis in renal epithelia in ex vivo
experiments [31], but has no effect in cell culture [32]. In the
current study, however, we found that anaesthesia and surgery did
not increase renal apoptosis in an animal model (Table 3). Other
workers have also shown that apoptosis in vivo is only enhanced in
the reperfusion phase after renal artery clamping [30, 33]. We
therefore suggest that there is balanced cell turnover in the
mature human kidney with lost cells either dying by apoptosis or
shed into the urine [34], and these are replaced by a low level of
epithelial proliferation [35].
Deregulation of apoptosis in polycystic kidneys
We have made a number of original observations regarding
apoptosis in polycystic kidneys obtained predominantly from
patients with ARPKD. Firstly, in the postnatal period, pyknotic
nuclei were observed in the interstitial tissue around undilated
proximal and distal tubules (Figs. 1 to 3), but we never observed
apoptosis in this location in normal postnatal kidneys. Secondly,
apoptotis occurred in hyperproliferative epithelium of distal cysts
(Figs. 1 and 3), and we also found undilated proximal tubules
dying by apoptosis between cysts (Fig. 3). Lastly, the incidence of
apoptosis was raised in postnatal polycystic kidneys (Table 3 and
Fig. 7). Next we sought evidence of apoptosis in the cpklcpk
mouse; here the kidney phenotypically resembles human
ARPKD, but the histology is more homogeneous and the disease
progression is highly predictable [18, 27]. We found that apoptosis
was increased, compared to phenotypically normal littermates, in
both an early and a late stage of renal disease (Table 3). The
animal data support our findings in human ARPKD and are also
in accord with a study reporting apoptosis in human ADPKD [36].
Thus, enhanced apoptosis is found in different types of polycystic
kidney disease. It is unknown how apoptosis relates to the genetic
defects in human polycystic kidney diseases [37—40]. Evidence for
a primary genetic deregulation of renal survival is, however,
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Table 3. Pyknotic index and percentage pyknotic nuclei in kidneys from
animal experiments outlined in the text
Percentage
Experimental
group Number
Pyknotic index!
mean (SD)
pyknotic nuclei/
mean (sD)
A
Normal newborn 4 0.61 (0.10) 0.02 (0.004)
Polycystic newborn 4 1.58 (0.14) 0.07 (0.007)
Normal 14 day 4 0.41 (0.29) 0.02 (0.008)
Polycystic 14 day 4 1.37 (0.26) 0.08 (0.008)
B
Control fetal mice 10 1.04 (0.76) 0.09 (0.06)
Storage for 24 hours 5 1.12 (0.84) 0.10 (0.07)
C
Control adult mice 6 0.44 (0.25) 0.04 (0.02)
Operative group 8 1.08 (0.79) 0.09 (0.07)
(Group A) Significantly more apoptosis in both cpk/cpk polycystic
groups compared to age matched controls (P < 0.001). (Group B) No
significant difference between fetal kidneys processed immediately or
stored in situ for 24 hours. (Group C) No significant difference in renal
apoptosis between control adult mice and operative group which under-
went anaesthesia and renal artery clamping.
provided by mice with bcl-2 null mutations which develop cystic
kidneys [41, 421. Moreover, transgenic mice which overexpress
c-myc develop renal cysts [43], and enhanced expression of this
cellular protooncogene occurs in cpklcpk mice [44, 51. C-myc
causes proliferation or apoptosis depending on the concentrations
of ambient growth factors [461, and thus the imbalance of EGF
[47, 48] and HGF [91 reported in polycystic kidney diseases may
affect cell survival. We speculate that proliferation and fluid
secretion in polycystic kidney epithelia [16, 19, 501 outweigh the
high levels of cell death reported in this study, hence causing
increased size of the kidneys with concomitant destruction of
functional renal tissue.
Deregulation of apoptosis in dysplastic kidneys
Most apoptosis in dysplastic kidneys occurred in cells located
around dysplastic tubules. Cells in this area superficially resemble
undifferentiated mesenchyme which, in the normal metanephros,
will differentiate into nephrons [11—131. We suggest that enhanced
apoptosis in dysplastic organs may prevent the differentiation of
these precursors. Moreover, we hypothesize that enhanced cell
death may contribute to the well-recognized phenomenon of
spontaneous involution of dysplastic kidneys [51—53]. During
normal nephrogenesis, bcl-2 is highly expressed in nephron pre-
cursors [54, 55], and this protein may be required to prevent the
death of cells during the mesenchymal to epithelial transition.
Preliminary data from our own laboratory [54] suggest that bel-2
is highly expressed in dysplastic tubules where apoptosis is rare,
but is only weakly expressed in undifferentiated cells where
prominent apoptosis is found. In humans, renal dysplasias may
occur in conjunction with renal obstruction (such as posterior
urethral valves) and some, but not all, animal studies suggest that
prenatal obstruction causes dysplasia [56—58]. Increased apopto-
sis is seen in experimental urinary obstruction in the postnatal
period [59, 601 and is associated with increased renal TGF-f3 [61],
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a molecule implicated in epithelial apoptosis [8]. However, only a
minority of our patients had obstructed kidneys (Tables 1 and 2).
Renal malformations occur in mice with null mutations for ret
[621, wnt-4 [631 and RARs [64], but apoptosis has not been studied
in these models, and none of them faithfully mimic human
multicystic renal dysplasia.
Conclusions
In summary, we have found that apoptosis occurs during
normal human kidney development in locations similar to those
reported in animals, and continues at a very low level after birth.
More importantly, apoptosis occurs at a high level in ARPKD and
dysplastic kidneys, which are important causes of end-stage renal
failure in infancy and childhood [21]. The fact that apoptosis can
be reduced by various molecular means both in vitro and in vivo [2,
14, 65] suggest novel therapeutic strategies for these diseases.
Acknowledgments
This work is supported by grants from Action Research to P.J.D.W.,
from the National Kidney Research Fund to A.S.W., and from the
Wellcome Trust to PH. We thank Drs. Philip Ransley, Patrick Duffy,
Jeeta Dhillon, Fergal Quinn and Helen Pardoe for their help in collecting
the surgical specimens, and Glenn Anderson, Dianne Rampling, and Sue
Howard for their technical assistance. Part of this work was presented in
abstract form at the 27th American Society of Nephrology meeting in
Orlando in October 1994.
Reprint requests to Dr. Paul i. D. Winyard, Developmental Biology Unit,
Institute of Child Health, 30, Guilfisrd Street, London WC1E JEH, England,
United Kingdom.
References
1. KERR JFR, WYLLIE AH, CtJRRIE AR: Apoptosis: A basic biological
phenomenon with wide ranging implications in tissue kinetics. Br J
Cancer 26:239-257, 1972
2. COLES HSR, BURNE JF, RAFF MC: Large-scale normal cell death in
the developing rat kidney and its reduction by epidermal growth
factor. Development 118:777—784, 1993
3. WYLLIE AH: Glucocorticoid-induced thymocye apoptosis is associ-
ated with endogenous endonuclease activation. Nature 284:555—556,
1980
4. GAVRELLI Y, SHERMAN Y, BEN-SASSOON SA: Identification of pro-
grammed cell death in situ via specific labeling of DNA fragmentation.
J Cell Biol 119:493—501, 1992
5. SCHWARTZ LM, SMITH SW, JONES ME, OSBORNE BA: Do all pro-
grammed cell deaths occur via apoptosis? Proc Nati Acad Sci USA
90:980—984, 1993
6. BORTNER CD, OLDENBURO NBE, CIDIOWSKI JA: The role of DNA
fragmentation in apoptosis. Trend Cell Biol 5:22—27, 1995
7. VAUX DL: Towards an understanding of the molecular mechanisms of
physiological cell death. Proc NatlAcad Sci USA 90:786—789, 1993
8. OBERHAMMER F, WILSON JW, DIVE C, MORRIS ID, HICKMANN JA,
WAKELING AE, WALKER PR, SIKORSKA M: Apoptotic death in
epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior
to or in the absence of intcrnucleosomal fragmentation. EMBO J
12:3679—3684, 1993
9. COLLINS MKL, PERKINS GR, RODRIGULZ-TARDUCIIY G, NIETO MA,
LoPEz-RIvAS A: Growth factors as survival factors: Regulation of
apoptosis. Bio Essays 16:133—138, 1994
10. WYLLIE AH, KERR JFR, CURRIE AR: Cell death: The significance of
apoptosis. mt Rev ytol 68:25 1—306, 1980
ii. POSTER EL: Normal and Abnormal Development of the Kidney. Chi-
cago, Year Book Medical Publishers Inc., 1972
12. SAXEN L: Organogenesis of the Kidney. Cambridge, Cambridge Uni-
versity Press, 1987
13. HARDMAN P, KOLATSI M, WINYARD PJ, TOWERS PR, WOOLF AS:
Branching Out with the ureteric bud. Exp Nephrol 2:211—219, 1994
14. KOSEKI C, HERZLINOER D, AL-AWOATI Q: Apoptosis in metanephric
development. J Cell Biol 119:1322—1333, 1992
15. WOOLF AS, KoITsI-JoANNou M, HARDMAN P, ANDERMARCHER E,
MOORBY C, FINE LG, JAT PS, NOBLE MD, GHERARDI E: Roles of
hepatocyte growth factor/scatter factor (HGF/SF) and met in early
development of the metanephros. J Cell Biol 128:171—184, 1995
16. WILSON PD, HRENIUK D, GABOW PA: Abnormal extracellular matrix
and excessive growth of human adult polycystic kidney disease epi-
thelia. J Cell Physiol 150:360—369, 1992
17. AVNER ED, SWEENEY WE, NELSON WJ: Abnormal sodium pump
distribution during renal tubulogenesis in congenital murine polycystic
kidney disease. Proc NatlAcad Sci USA 89:7447—7451, 1992
18. Woo DDL, MIA0 5, PELAYO J, WOOLF AS: Taxol inhibits congenital
polycystic kidney disease progression. Nature 368:750—753, 1994
19. GRANTHAM JJ: 1992 Homer Smith Award. Fluid secretion, cellular
proliferation, and the pathogenesis of renal epithelial cysts. JAm Soc
Nephrol 3:1841—1857, 1992
20. RISDON RA: Renal dysplasia. Part 1: A clinico-pathological study of 76
cases. J Clin Pathol 24:57—71, 1971
21. WOOLF AS: Clinical impact and biological basis of renal malforma-
tions.Semin Nephrol 15:361—372, 1995
22. KREIDBERG JA, SARIOLA H, LORING JM, MAEDA M, PELLETIER J,
HOUSMAN D, JAENISCH R: WT-1 is required for early kidney devel-
opment. Cell 74:679—691, 1991
23. VERANI R, WALKER P, SILVA FG: Renal cystic disease of infancy:
Results of histochemical studies. Pediatr Nephrol 3:37—42, 1989
24. HOLTHOFFER H, VIRTANEN 1, PETI-ERSSON E, T0RNR0TH T, AI.F-rHAN
0, LINDER E, MIEITINEN A: Lectins as fluorescence microscopic
markers for saccharides in the human kidney. Lab Invest 45:391—399,
1981
25. BLAND JM, ALTMANN DG: Statistical methods for assessing agree-
ment between two methods of clinical measurement. Lancet 8476:
307—3 10, 1986
26. SAMBROOK J, FRITSCH EF, MANIATIS T: Molecular Cloning: A Labo-
ratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory
Press, 1989
27. AVNER ED, STUDNICKI FE, YOUNG MC, SWEENEY WE JR, PlEsco NP,
ELLIS D, FEI-FERMAN GH: Congenital murine polycystic kidney dis-
ease. Pediatr Nephrol 1:587—596, 1987
28. GATrONE VH II, CALVET JP, COWLEY BD JR, EVAN AP, SHAVER TS,
HEIMSTADTER K, GRANTHAM JJ: Autosomal recessive polycystic
kidney disease in a murine model. A gross and microscopic descrip-
tion. Lab Invest 59:231—238, 1988
29. SAVILL J, SMITH J, SARRAF C, REN Y, ABBOTr F, REES A: Glomerular
mesangial cells and inflammatory macrophages ingest neutrophils
undergoing apoptosis. Kidney mt 42:924—936, 1992
30. SCHEMER M, COLOMBEL MC, SAWCZUK IS, GOBE G, CONNOR J,
O'ToOLE KM, OLSSON CA, WISE GJ, BUTrYAN R: Morphological,
biochemical and molecular evidence of apoptosis during the reperfu-
sion phase after brief periods of renal ischemia. Am J Pathol 140:831—
838, 1992
31. BEERI R, SYMON Z, BREZIS M, BEN-SAS5ON SA, BAEHR PH, ROSEN 5,
ZAGER RA: Rapid DNA fragmentation from hypoxia along the thick
ascending limb of rat kidneys. Kidney Int 47:1806—1810, 1995
32. IWATA M, TOROK-STORB B, ZAGER RA: An evaluation of renal
tubular DNA laddering in response to oxygen deprivation and oxidant
injury. JAm Soc Nephrol 5:1307—1313, 1994
33. FUERSTENBERG SM, TOROK-STRAUB B, ZAGER RA: Evidence against
apoptosis as a dominant mechanism for post-ischemic/post-hypoxic
proximal tubular necrosis. (abstract) JAm Soc Nephrol 4:735, 1993
34. RACUSEN LC, FIVUSII BA, ANDERSSON H, GAHL WA: Culture of renal
tubular cells from the urine of patients with nephropathic cystinosis. J
Am Soc Nephrol 1:1028—1033, 1991
35. LAURENT G, TOUBEAU G, HEUSON-STIENNON JA, TULKEN5 P, MALDA-
GEE P: Kidney tissue repair after nephrotoxic injury: Biochemical and
morphological characterisation. CRC Crit Rev Toxicol 19:147—183,
1988
36. Woo DDL: Apoptosis and loss of renal tissue in polycystic kidney
diseases. N EngI J Med 333:18—25, 1995
37. ZERRES K, MUCHER G, BACILNER L, DESCHENNES G, EGGERMAN T,
KAARIAINEN H, KNAPP M, LENNERT T, MIssELwITz J, VON MUNLEN-
I)AIIL KB, NEUMANN HPH, PIR50N Y, RUDNIK-SCHONEBORN 5, STEIN-
BICKER V, WIRTH B, SCHARER K: Mapping of the gene for autosomal
146 Winyard ci al: Apoptosis in cystic and dysplastic kidneys
recessive polycystic kidney disease (ARPKD) to chromosome 6p2l-
cen. Nature Genet 7:429—432, 1994
38. EUROPEAN POLYCYSTIC KIDNEY DISEASE CONSORTIUM: The polycystic
kidney disease I gene encodes a 14 kb transcript and lies within a
duplicated region on chromosome 16. Ccli 77:881—894, 1994
39. EUROPEAN CHROMOSOME 16 TUBEROUS SCLEROSIS CONSORTIUM:
Identification and characterisation of the tuberous sclerosis gene on
chromosome 16. Cell 75:1305—1315, 1993
40. LATIF F, TORY K, GNARRA J, YAO M, DUH F-M, ORCUTr ML,
STACKHOUSE T, KUZMIN I, Mom W, GEIL L, SCHMIDT L, ZHOU F, LI
H, WEI MH, CHEN F, GLENN G, CHOYKE P, WALTHER MM, WENG Y,
DUAN D-SR, DEAN M, GLAVAC D, RICHARDS FM, CROSSEY PA,
FERGUSON-SMITH MA, LE PA5LIER D, CHUMAKOV I, COHEN D,
CHINAULT AC, MAHER ER, LINEHAN WM, ZBAR B, LERMAN MI:
Identification of the von Hippel-Lindau disease tumor suppressor
gene. Science 260:1317—1320, 1993
41. VEIS DJ, SORENSON CM, SHUTFER JR, KORSMEYER SJ: bcl-2-deficient
mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys
and hypopigmented hair. Cell 75:229—240, 1994
42. SORENSON CM, ROGERS SA, KORSEMEYER SJ, HAMMERMAN MR:
Fulminant metanephric apoptosis in abnormal kidney development in
bcl-2 deficient mice. Am J Physiol 268:73—81, 1995
43. TRUDEL M, D'AGATI V, C05TANTINI F: C-myc as an inducer of
polycystic disease in transgenic mice. Kidney mt 39:665—671, 1991
44. COWLEY BD JR, SMARDO FL JR, GRANTHAM JJ, CALVET JP: Elevated
c-myc proto-Oncogene expression in autosomal recessive polycystic
kidney disease. Proc Soc Nail Acad Sci USA 84:8394—8398, 1987
45. HARDING MA, GATrONE VH II, GRANTHAM JJ, CALVET JP: Localiza-
tion of overexpressed c-myc mRNA in polycystic kidneys of the cpk
mouse. Kidney mt 41:317—325, 1992
46. HARRINGTON EA, BENNETr MR, FANIDI A, EVAN GI: c-Myc induced
apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J
13:3286—3295, 1994
47. GATrONE VH II, ANDREWS GK, FU-WEN N, CHADWICK U, KLEIN
RM, CALVET JP: Defective epidermal growth factor gene expression
in mice with polycystic kidney disease. Dcv Biol 138:225—230, 1990
48. H0RIKOsHI 5, KUBOTA S, MARTIN GR, YAMADA Y, KLOTMAN PE:
Epidermal growth factor (EGF) in the congenital polycystic mouse
kidney. Kidney In! 39:57—62, 1991
49. HORIE 5, HIGASFIIHARA E, NUTAHARA K, MIKAMI Y, OKUBO A, KANO
M, KAWABE K: Mediation of renal cyst formation by hepatocyte
growth factor. Lancet 344:789—791, 1994
50. YE M, GRANTHAM JJ: The secretion of fluid by renal cysts from
patients with autosomal dominant polycystic kidney disease. N Engi J
Med 329:310—313, 1993
51. DUNGAN JS, FERNANDEZ MT, Aanirr PL, THIAGARAJAH S. HOWARDS
SS, HOGGE WA: Multicystic dysplastic kidney: Natural history of
prenatally detected cases. Prenat Diag 10:175—182, 1990
52. ME5ROBIAN H-GJ, RUSHTON HG, BULAS D: Unilateral renal agenesis
may result from in utero regression of multicystic dysplasia. J Urol
150:793—794, 1993
53. AL-KHALDI N, WATSON AR, ZUCOLLO J, TWINING P, ROSE DH:
Outcome of antenatally detected cystic dysplastic kidney disease. Arch
Dis Child 70:520—522, 1994
54. WINYARD PJD, RISDON RA, WOOLF AS: WT1 expression in the
absence of BCL2 may explain excessive apoptosis which occurs in
human kidney malformations. (abstract) JAm Soc Nephroi 6:729, 1995
55. LEBRUN DP, WARNKE RA, CLEARY ML: Expression of bcl-2 in fetal
tissues suggests a role in morphogenesis. Am J Pathol 142:743—753,
1993
56. BERMAN D, MAIZELS M: The role of urinary obstruction in the genesis
of renal dysplasia. J Urol 128:1091—1100, 1982
57. STEINHARDT GF, VOGLER G, SALINAS-MADRIGAL L, LEREGINA M:
Induced renal dysplasia in the young pouch opossum. J Ped Surg
23:1127—1130, 1988
58. GONZALEZ R, REINBERG Y, BURKE B, WELLS T, VERNIER RL: Early
bladder outlet obstruction in fetal lambs induces renal dysplasia and
the prune-belly syndrome. J Pediatr Surg 25:342—334, 1990
59. CONNOR J, BU1-I-YAN R, OLSSON CA, D'AGATI V, O'TooLE K,
SAWCZUK IS: SGP-2 expression as a genetic marker of progressive
cellular pathology in experimental hydronephrosis. Kidney mt 39:
1098—1103, 1991
60. KENNEDY WA II, STERNBERG A, LACKGREN G, HERNSLE TW, SAWC-
ZUK IS: Renal tubular apoptosis after partial ureteral obstruction. J
Uroi 152:658—664, 1994
61. PIMENTEL JL, K0PP JB, SUNDEN JL, MARTINEZ-MALDONADO M:
TGF-/3 induction in unilateral ureteric obstruction. (abstract) J Am
Soc Nephrol 4:474, 1993
62. SCHUCHARDT A, D'AGATI V, LARSSON-BLOMBERG L, COSTANTINI F,
PACHNIS V: Defects in kidney and enteric nervous system of mice
lacking the tyrosine kinase receptor Ret. Nature 367:380—383, 1994
63. STARK K, VAINIO 5, VASSILEVA G, MCMAHON AP: Epithelial trans-
formation of metanephric mesenchyme in the developing kidney
regulated by Wnt-4. Nature 372:679—683, 1994
64. MENDELSOHN C, LOHNES D, DEcIM0 D, LUFKIN T, LEMEUR M,
CHAMBON P, MARK M: Function of the retinoic acid receptors (RAR)
during development. Development 120:2749—2771, 1994
65. KENNEDY WA II, BUnYAN R, SAWCZUK IS: Epidermal growth factor
(EGF) suppresses renal tubular apoptosis following ureteral obstruc-
tion. (abstract) JAm Soc Nephrol 4:738, 1993
